“…Questionnaire after reviewing the literature. 2,6,8,9,[13][14][15] The form consists of questions used to determine sociodemographic characteristics, clinical features, and potential postoperative complications and symptoms. Clinical features include medical diagnosis, hospital LOS, surgical history, pain level and post-surgical ambulation time and first oral intake time.…”
Section: The Investigators Developed the Participant Descriptionmentioning
confidence: 99%
“…The use of robotic equipment for gynecologic surgical procedures was first cleared by the US Food and Drug Administration in 2005. Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re‐anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery 2–4 . In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008 5 .…”
Section: Introductionmentioning
confidence: 99%
“…offered robotic surgery as the treatment of choice for gynecologic disorders. 1,2,4 As the number and type of robotic gynecologic surgical procedures continue to increase, little information appears in the nursing literature regarding health-related quality of life (HRQoL) of patients undergoing robotic surgery, which is an important factor in the preference shown by patients for a surgical approach. 6 HRQoL is a patient-reported outcome measure and part of an important reflection of treatment or disease-related adverse effects.…”
mentioning
confidence: 99%
“…Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re-anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery. [2][3][4] In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008. 5 Robotic surgery in gynecology has been characterized by less blood loss, fewer transfusions, reduced hospital length of stay (LOS), and overall reduced complications, with patients advancing to a regular diet and early ambulation in the postoperative period.…”
Technological advances continue to revolutionize the surgical treatment of gynecologic conditions. 1 A recent innovation in the field of minimally invasive surgery is robot-assisted surgery, also known as robotic surgery, which offers the advantages of dimensional visual system, improved dexterity with wristed instrumentation, and elimination of hand tremors. The use of robotic equipment for gynecologic surgical procedures was first cleared by the US Food and Drug Administration in 2005. Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re-anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery. [2][3][4] In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008. 5 Robotic surgery in gynecology has been characterized by less blood loss, fewer transfusions, reduced hospital length of stay (LOS), and overall reduced complications, with patients advancing to a regular diet and early ambulation in the postoperative period. Therefore, in high-income countries, an increasing number of women are being
“…Questionnaire after reviewing the literature. 2,6,8,9,[13][14][15] The form consists of questions used to determine sociodemographic characteristics, clinical features, and potential postoperative complications and symptoms. Clinical features include medical diagnosis, hospital LOS, surgical history, pain level and post-surgical ambulation time and first oral intake time.…”
Section: The Investigators Developed the Participant Descriptionmentioning
confidence: 99%
“…The use of robotic equipment for gynecologic surgical procedures was first cleared by the US Food and Drug Administration in 2005. Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re‐anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery 2–4 . In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008 5 .…”
Section: Introductionmentioning
confidence: 99%
“…offered robotic surgery as the treatment of choice for gynecologic disorders. 1,2,4 As the number and type of robotic gynecologic surgical procedures continue to increase, little information appears in the nursing literature regarding health-related quality of life (HRQoL) of patients undergoing robotic surgery, which is an important factor in the preference shown by patients for a surgical approach. 6 HRQoL is a patient-reported outcome measure and part of an important reflection of treatment or disease-related adverse effects.…”
mentioning
confidence: 99%
“…Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re-anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery. [2][3][4] In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008. 5 Robotic surgery in gynecology has been characterized by less blood loss, fewer transfusions, reduced hospital length of stay (LOS), and overall reduced complications, with patients advancing to a regular diet and early ambulation in the postoperative period.…”
Technological advances continue to revolutionize the surgical treatment of gynecologic conditions. 1 A recent innovation in the field of minimally invasive surgery is robot-assisted surgery, also known as robotic surgery, which offers the advantages of dimensional visual system, improved dexterity with wristed instrumentation, and elimination of hand tremors. The use of robotic equipment for gynecologic surgical procedures was first cleared by the US Food and Drug Administration in 2005. Since then, robotic surgery has been used in gynecology for procedures including hysterectomy, myomectomy, tubal re-anastomosis, ovarian transposition, gynecologic oncology procedures, and pelvic reconstructive surgery. [2][3][4] In Turkey, robotic equipment (da Vinci® surgical system) in gynecology was first used for hysterectomy in 2008. 5 Robotic surgery in gynecology has been characterized by less blood loss, fewer transfusions, reduced hospital length of stay (LOS), and overall reduced complications, with patients advancing to a regular diet and early ambulation in the postoperative period. Therefore, in high-income countries, an increasing number of women are being
“…Robotic-assisted surgery provides advantages for patient and also health care professions (1). These advantages have led to more widespread use of robotic-assisted surgery in several specialties (2).…”
The aim of this study is to improve the understanding of the experiences of women undergoing robotic-assisted gynecologic surgery. Methods: A qualitative descriptive phenomenologic approach was used. We conducted phone interviews with women who had undergone a gynecologic procedure via robotic-assisted surgery in a gynecology clinic of a university hospital (n=19). Semi-structured interviews were conducted with women, and data were analyzed using Colaizzi's methods. Results: Two major themes were identified. These two themes concerned: (1) Ambivalent Feelings on Robotic Surgery, and (2) Robotic Surgery was a Piece of Cake. Conclusions: Because of the newness of this procedure, the women in this study indicated that they had concerns and lacked information about robotic-assisted gynecologic surgery but that their decision was influenced by the confidence they had in their physicians. The women indicated that they had confidence in the robotic technique and recovered quickly physically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.